Jump to ContentJump to Main Navigation
Show Summary Details

Forum of Clinical Oncology

DE GRUYTER OPEN

Open Access

    Open Access
    Online
    ISSN
    1792-362X
    See all formats and pricing
    


    Select Volume and Issue
    Loading journal volume and issue information...

    Overview

    Aims and Scope

    Why subscribe and read

    We would like to present to you the Forum of Clinical Oncology (FCO), the official scientific journal of the Hellenic Society of Medical Oncology.
    In the Hellenic Society of Medical Oncology we want FCO to serve as a forum, for us all, to communicate clinical and research achievements in English; to share thoughts, opinions, facts, problems and solutions.
    We envision the journal to be the means, by which our efforts in the fight against cancer will become known to a wider audience, thus establishing our presence in the global setting. FCO publishes original and translational research articles relevant to diagnosis and treatment of cancer, state-of-the-art reviews, case reports, research articles, statements of opinion and comments, all related to clinical practice and basic research. A large number of eminent Greek and Foreign colleagues who participate in the National and International Editorial Boards, with their continuum direction and support, guarantee the high quality of the work published in FCO. In every issue published there will be something new, enjoyable and exciting to be read.

    Why submit

    We would like to welcome you to the Forum of Clinical Oncology (FCO), the official scientific journal of the Hellenic Society of Medical Oncology.
    In the Hellenic Society of Medical Oncology we share the view that there are many issues we deal with in our everyday clinical and research practice that are common to our colleagues geographically closer to us, in the Balkans and the Mediterranean basin, but also to those in other parts of the world. That led us to dare "the great leap forward": to broaden the scope of our Greek scientific journal for oncology, published in Greek for the last 10 years, and develop Forum of Clinical Oncology a web based open access journal in English.

    FCO will serve as a forum for us all to communicate clinical and research achievements. One of the innovations of the journal is its online management from submission of an article to its publication. Online is more efficient: submitting, reviewing, proofreading, filing and indexing. However, the most important benefit of all is easy universal access.

    English has become the common language amongst scientists from around the globe. This is the reason why we chose English as the official language of the journal. Many Greek colleagues have already published work in English in distinguished journals or have studied or worked abroad. We believe that the language change will not be an impediment for our Greek colleagues to present their work in FCO, whereas on the other hand it will allow our colleagues from other countries to participate.

    The Forum of Clinical Oncology publishes original and translational research articles relevant to diagnosis and treatment of cancer, state-of-the-art reviews, case reports, research articles, statements of opinion and comments, all related to clinical practice and basic research.

    We share the view that there should be no barriers to knowledge and thus, we decided Forum of Clinical Oncology to be an open-access journal, i.e., any work submitted to the journal and accepted for publication shall be made immediately available to the scientific community and the general public, via the journal's website and printed version. Authors are requested to adjust accordingly the information regarding their work they wish to make public. It is the desire of the editorial team to make this journal an interactive educational tool to acquire knowledge and it is addressed to scientists working with oncology.

    Please join us in our effort and submit your work to the FCO.

    Details

    DE GRUYTER OPEN
    Language:
    English
    Type of Publication:
    Journal

    Submission of Manuscripts

    Instructions for Authors

    Please submit your manuscripts to Forum of Clinical Oncology via email to:

    hesmo@otenet.gr

    More ...

    Abstracting & Indexing

    Forum of Clinical Oncology is covered by the following services:

    • Baidu Scholar
    • Celdes
    • CNKI Scholar (China National Knowledge Infrastructure)
    • CNPIEC
    • DOAJ (Directory of Open Access Journals)
    • EBSCO Discovery Service
    • Elsevier - SCOPUS
    • Genamics JournalSeek
    • Google Scholar
    • J-Gate
    • JournalTOCs
    • Naviga (Softweco)
    • Primo Central (ExLibris)
    • ReadCube
    • ResearchGate
    • SCImago (SJR)
    • Summon (Serials Solutions/ProQuest)
    • TDOne (TDNet)
    • Ulrich's Periodicals Directory/ulrichsweb
    • WorldCat (OCLC)

    Editorial Information

    Editor-in-Chief
    Sofia Agelaki, Medical School, University of Crete, Greece

    Deputy/ Managing Editor
    Zenia Saridaki, Asklepios Medical Centre, Greece

    Advisory Editorial Board
    Rene Adam, Paul Brousse Hospital, France
    Athanassios Argiris, University of Pittsburgh School of Medicine, United States
    Vassileios Avramis, Children's Hospital Los Angeles, United States
    Lodovico Balducci, Lee Moffitt Cancer Center and Research Institute, United States
    George Peter Canellos, Harvard Medical School, United States
    J.Y. Douillard, Medical Oncology Branch, Centre R. Gauducheau, France
    George Demetri, Dana-Farber Cancer Institute, United States
    Spyros Linardopoulos, Cancer Research UK Centre for Cancer Therapeutics, Chester Beatty Laboratories, United Kingdom
    Terry Mamounas, Cancer Center, Aultman Health Foundation, United States
    Anthony Maraveyas, Castle Hill Hospital, United Kingdom
    Vassiliki Papadimitrakopoulou, UT/MD Anderson Cancer Center, United States
    George Pavlakis, NCI at Frederick, United States
    Spyros Retsas, Cromwell Hospital, United Kingdom
    Philippe Rougier, Department of Gastroenterology, Hospital Ambroise Paris, France
    Giorgio Scaglioti, University of Torino, San Luigi Hospital, Italy
    T.C. Theoharides, Tufts University School of Medicine, Tufts Medical Center, United States

    Editors
    Athanassios Anagnostopoulos, Henry Dunant Hospital, Greece
    Gerasimos Aravantinos, "Agioi Anargyroi" Hospital, Greece
    Athanassios Athanassiadis, General Hospital of Larissa "Koutlimpaneio & Triantafylleio", Greece
    Dimitrios Bafaloukos, Metropolitan Hospital, Greece
    Aristotelis Bamias, University General Hospital of Athens "Alexandra", Greece
    Ioannis Boukovinas, Theageneio Anticancer Hospital, Greece
    Christos Emmanouilides, Interbalkan Medical Center, Greece
    Helen Gogas, University General Hospital of Athens "Laiko", Greece
    Stylianos Kakolyris, University General Hospital of Alexandroupoli, Greece
    Athanasios Karampeazis, 401 General Military Hospital of Athens, Greece
    Michael Karamouzis, Medical School, University of Athens, Greece
    Ourania Katopodi, Bioclinic of Athens, Greece
    Georgios Klouvas, Metropolitan Hospital, Greece
    Christos Kosmas, General Anticancer Hospital "Metaxa", Greece
    Georgios Koumakis, "Agios Savvas" Anticancer Hospital, Greece
    Thomas Makatsoris, University General Hospital of Patra - Rio, Greece
    Dimitris Mavroudis, University General Hospital of Heraklion, Greece
    Michael Nikolaou, "Ippokrateion" University Hospital of Athens, Greece
    Christos Panopoulos, "Agios Savvas" Anticancer Hospital, Greece
    Christos Papadimitriou, University General Hospital of Athens "Alexandra", Greece
    Christos Papandreou, University General Hospital of Larissa, Greece
    Konstantinos Papazissis, Theageneio Anticancer Hospital, Greece
    Dimitrios Pectasides, General Hospital of Athens "Ippokratio", Greece
    Georgios Pentheroudakis, University General Hospital of Ioannina, Greece
    Amanda Psyrri, University General Hospital of Athens "Attikon", Greece
    Evangelia Razis, Hygeia Hospital, Greece
    Georgios Samonis, University General Hospital of Heraklion, Greece
    Ioannis Souglakos, University General Hospital of Heraklion, Greece
    Kyriakos Souliotis, Associate Professor, University of Peloponnese, Greece
    Kostas Syrigos, "Sotiria" Regional Chest Diseases Hospital of Athens, Greece
    Dimitrios Tryfonopoulos, "Agios Savvas" Anticancer Hospital, Greece
    Lambros Vamvakas, University General Hospital of Heraklion, Greece
    Michael Vaslamatzis, General Hospital of Athens "Evaggelismos", Greece
    Spyridon Xynogalos, General Hospital of Athens "Evaggelismos", Greece
    Nikolaos Ziras, General Anticancer Hospital "Metaxa", Greece

    Section Editors
    Genetics 
    Koulis Giannoukakos, NSCR Demokritos, Greece
    Emmanouil Saloustros, General Hospital of Heraklion "Venizeleio- Pananeio", Greece

    Medical Oncology
    Charalambos Andreadis, Theageneio Anticancer Hospital, Greece
    Dimitrios Mavroudis, University of Crete, Greece
    Evaggelos Briasoulis, University of Ioannina, Greece

    Molecular Biology
    Sam Murray, Genekor SA, Greece
    Vasiliki Kotoula, University of Thessaloniki, Greece

    Pathology
    Petroula Arapantoni-Dadioti, Metropolitan Hospital General Anticancer Hospital "Metaxa", Greece
    Savvas Papadopoulos, Hygeia Hospital, Greece

    Radiation Oncology
    Dimitris Kardamakis, University of Patras, Greece
    Despoina Misailidou, Interbalkan Medical Centre, Greece

    Surgical Oncology
    Odysseas Zoras, Medical School University General Hospital of Heraklion, Greece
    Evaggelos Xynos, University Hospital of Herakleion, Greece

    Contact  
    hesmo@otenet.gr

    Publisher
    DE GRUYTER OPEN
    Bogumiła Zuga 32A Str.
    01-811 Warsaw, Poland

    Comments (0)

    Please log in or register to comment.